<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24027313</PMID><DateCompleted><Year>2014</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>87</Volume><Issue>22</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Human astrocytic cells support persistent coxsackievirus B3 infection.</ArticleTitle><Pagination><StartPage>12407</StartPage><EndPage>12421</EndPage><MedlinePgn>12407-21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.02090-13</ELocationID><Abstract><AbstractText>Enteroviruses can frequently target the human central nervous system to induce a variety of neurological diseases. Although enteroviruses are highly cytolytic, emerging evidence has shown that these viruses can establish persistent infections both in vivo and in vitro. Here, we investigated the susceptibility of three human brain cell lines, CCF-STTG1, T98G, and SK-N-SH, to infection with three enterovirus serotypes: coxsackievirus B3 (CVB3), enterovirus 71, and coxsackievirus A9. Persistent infection was observed in CVB3-infected CCF-STTG1 cells, as evidenced by prolonged detection of infectious virions, viral RNA, and viral antigens. Of note, infected CCF-STTG1 cells expressed the nonfunctional canonical viral receptors coxsackievirus-adenovirus receptor and decay-accelerating factor, while removal of cell surface chondroitin sulfate from CCF-STTG1 cells inhibited the replication of CVB3, suggesting that receptor usage was one of the major limiting factors in CVB3 persistence. In addition, CVB3 curtailed the induction of beta interferon in infected CCF-STTG1 cells, which likely contributed to the initiation of persistence. Furthermore, proinflammatory chemokines and cytokines, such as vascular cell adhesion molecule 1, interleukin-8 (IL-8), and IL-6, were upregulated in CVB3-infected CCF-STTG1 cells and human progenitor-derived astrocytes. Our data together demonstrate the potential of CCF-STTG1 cells to be a novel cell model for studying CVB3-central nervous system interactions, providing the basis toward a better understanding of CVB3-induced chronic neuropathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaowei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Zhenhua</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Shu</LastName><ForeName>Bo</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xijuan</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhenfeng</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Bingke</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Qinxue</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Panyong</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hanzhong</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018958">CD55 Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062727">Coxsackie and Adenovirus Receptor-Like Membrane Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016209">Interleukin-8</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018958" MajorTopicYN="N">CD55 Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062727" MajorTopicYN="N">Coxsackie and Adenovirus Receptor-Like Membrane Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016209" MajorTopicYN="N">Interleukin-8</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24027313</ArticleId><ArticleId IdType="pmc">PMC3807905</ArticleId><ArticleId IdType="doi">10.1128/JVI.02090-13</ArticleId><ArticleId IdType="pii">JVI.02090-13</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nasri D, Bouslama L, Pillet S, Bourlet T, Aouni M, Pozzetto B. 2007. Basic rationale, current methods and future directions for molecular typing of human enterovirus. Expert Rev. Mol. Diagn. 7:419&#x2013;434</Citation><ArticleIdList><ArticleId IdType="pubmed">17620049</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles NJ, Hovi T, Hyypi&#xe4; T, King AMQ, Lindberg AM, Pallansch MA, Palmenberg AC, Simmonds P, Skern T, Stanway G, Yamashita T, Zell R. 2012. Picornaviridae, p 855&#x2013;880 In King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. (ed), Virus taxonomy: classification and nomenclature of viruses. Ninth report of the International Committee on Taxonomy of Viruses. Elsevier, San Diego, CA</Citation></Reference><Reference><Citation>Hober D, Sauter P. 2010. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat. Rev. Endocrinol. 6:279&#x2013;289</Citation><ArticleIdList><ArticleId IdType="pubmed">20351698</ArticleId></ArticleIdList></Reference><Reference><Citation>Baboonian C, Treasure T. 1997. Meta-analysis of the association of enteroviruses with human heart disease. Heart 78:539&#x2013;543</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1892342</ArticleId><ArticleId IdType="pubmed">9470867</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacques J, Moret H, Minette D, Leveque N, Jovenin N, Deslee G, Lebargy F, Motte J, Andreoletti L. 2008. Epidemiological, molecular, and clinical features of enterovirus respiratory infections in French children between 1999 and 2005. J. Clin. Microbiol. 46:206&#x2013;213</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2224256</ArticleId><ArticleId IdType="pubmed">18003804</ArticleId></ArticleIdList></Reference><Reference><Citation>Michos AG, Syriopoulou VP, Hadjichristodoulou C, Daikos GL, Lagona E, Douridas P, Mostrou G, Theodoridou M. 2007. Aseptic meningitis in children: analysis of 506 cases. PLoS One 2:e674.10.1371/journal.pone.0000674</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0000674</ArticleId><ArticleId IdType="pmc">PMC1933255</ArticleId><ArticleId IdType="pubmed">17668054</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoades RE, Tabor-Godwin JM, Tsueng G, Feuer R. 2011. Enterovirus infections of the central nervous system. Virology 411:288&#x2013;305</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3060663</ArticleId><ArticleId IdType="pubmed">21251690</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitton JL, Cornell CT, Feuer R. 2005. Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 3:765&#x2013;776</Citation><ArticleIdList><ArticleId IdType="pubmed">16205710</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K-S, Tracy S, Tapprich W, Bailey J, Lee C-K, Kim K, Barry W, Chapman N. 2005. 5&#x2032;-terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J. Virol. 79:7024&#x2013;7041</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1112132</ArticleId><ArticleId IdType="pubmed">15890942</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia J, Chia A, Voeller M, Lee T, Chang R. 2010. Acute enterovirus infection followed by myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and viral persistence. J. Clin. Pathol. 63:165&#x2013;168</Citation><ArticleIdList><ArticleId IdType="pubmed">19828908</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman NM, Kim KS. 2008. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr. Top. Microbiol. 323:275&#x2013;292</Citation><ArticleIdList><ArticleId IdType="pubmed">18357775</ArticleId></ArticleIdList></Reference><Reference><Citation>Muir P, Nicholson F, Tilzey AJ, Signy M, English TA, Banatvala JE. 1989. Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet i:804&#x2013;807</Citation><ArticleIdList><ArticleId IdType="pubmed">2564902</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridgens R, Sturman S, Davidson C, Expert BPFs. 2010. Post-polio syndrome&#x2014;polio's legacy. Clin. Med. 10:213&#x2013;214</Citation><ArticleIdList><ArticleId IdType="pubmed">20726444</ArticleId></ArticleIdList></Reference><Reference><Citation>Leparc-Goffart I, Julien J, Fuchs F, Janatova I, Aymard M, Kopecka H. 1996. Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome. J. Clin. Microbiol. 34:2023&#x2013;2026</Citation><ArticleIdList><ArticleId IdType="pmc">PMC229177</ArticleId><ArticleId IdType="pubmed">8818905</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaidane H, Caloone D, Lobert PE, Sane F, Dardenne O, Naquet P, Gharbi J, Aouni M, Geenen V, Hober D. 2012. Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor. J. Virol. 86:11151&#x2013;11162</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3457166</ArticleId><ArticleId IdType="pubmed">22855493</ArticleId></ArticleIdList></Reference><Reference><Citation>Brilot F, Chehadeh W, Charlet-Renard C, Martens H, Geenen V, Hober D. 2002. Persistent infection of human thymic epithelial cells by coxsackievirus B4. J. Virol. 76:5260&#x2013;5265</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136150</ArticleId><ArticleId IdType="pubmed">11967339</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanone MM, Favaro E, Conaldi PG, Greening J, Bottelli A, Perin PC, Klein NJ, Peakman M, Camussi G. 2003. Persistent infection of human microvascular endothelial cells by coxsackie B viruses induces increased expression of adhesion molecules. J. Immunol. 171:438&#x2013;446</Citation><ArticleIdList><ArticleId IdType="pubmed">12817028</ArticleId></ArticleIdList></Reference><Reference><Citation>Heim A, Canu A, Kirschner P, Simon T, Mall G, Hofschneider PH, Kandolf R. 1992. Synergistic interaction of interferon-beta and interferon-gamma in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts. J. Infect. Dis. 166:958&#x2013;965</Citation><ArticleIdList><ArticleId IdType="pubmed">1328409</ArticleId></ArticleIdList></Reference><Reference><Citation>Heim A, Grumbach I, Pring-Akerblom P, Stille-Siegener M, Muller G, Kandolf R, Figulla HR. 1997. Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-alpha. Antiviral Res. 34:101&#x2013;111</Citation><ArticleIdList><ArticleId IdType="pubmed">9191017</ArticleId></ArticleIdList></Reference><Reference><Citation>Heim A, Brehm C, Stille-Siegener M, Muller G, Hake S, Kandolf R, Figulla HR. 1995. Cultured human myocardial fibroblasts of pediatric origin: natural human interferon-alpha is more effective than recombinant interferon-alpha 2a in carrier-state coxsackievirus B3 replication. J. Mol. Cell. Cardiol. 27:2199&#x2013;2208</Citation><ArticleIdList><ArticleId IdType="pubmed">8576936</ArticleId></ArticleIdList></Reference><Reference><Citation>Conaldi PG, Biancone L, Bottelli A, De Martino A, Camussi G, Toniolo A. 1997. Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells. J. Virol. 71:9180&#x2013;9187</Citation><ArticleIdList><ArticleId IdType="pmc">PMC230220</ArticleId><ArticleId IdType="pubmed">9371576</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinkert S, Klingel K, Lindig V, Dorner A, Zeichhardt H, Spiller OB, Fechner H. 2011. Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line. J. Virol. 85:13409&#x2013;13419</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3233118</ArticleId><ArticleId IdType="pubmed">21976640</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman NM, Kim K-S, Drescher KM, Oka K, Tracy S. 2008. 5&#x2032; terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart. Virology 375:480&#x2013;491</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2440640</ArticleId><ArticleId IdType="pubmed">18378272</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam PE, Messner RP. 1999. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J. Virol. 73:10113&#x2013;10121</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113063</ArticleId><ArticleId IdType="pubmed">10559326</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer R, Ruller CM, An N, Tabor-Godwin JM, Rhoades RE, Maciejewski S, Pagarigan RR, Cornell CT, Crocker SJ, Kiosses WB. 2009. Viral persistence and chronic immunopathology in the adult central nervous system following coxsackievirus infection during the neonatal period. J. Virol. 83:9356&#x2013;9369</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2738251</ArticleId><ArticleId IdType="pubmed">19570873</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselin A-S, Simonin Y, Guivel-Benhassine F, Rincheval V, Vayssiere J-L, Mignotte B, Colbere-Garapin F, Couderc T, Blondel B. 2003. Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells. J. Virol. 77:790&#x2013;798</Citation><ArticleIdList><ArticleId IdType="pmc">PMC140570</ArticleId><ArticleId IdType="pubmed">12477887</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavio N, Couderc T, Girard S, Sgro JY, Blondel B, Colbere-Garapin F. 2000. Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus. Virology 274:331&#x2013;342</Citation><ArticleIdList><ArticleId IdType="pubmed">10964776</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson JP, Righthand VF. 1985. Persistence of echovirus 6 in cloned human cells. J. Virol. 54:219&#x2013;223</Citation><ArticleIdList><ArticleId IdType="pmc">PMC254780</ArticleId><ArticleId IdType="pubmed">3973978</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin DE. 2003. Immune responses to RNA-virus infections of the CNS. Nat. Rev. Immunol. 3:493&#x2013;502</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097089</ArticleId><ArticleId IdType="pubmed">12776209</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmann CC, Lane TE, Stohlman SA. 2006. Coronavirus infection of the central nervous system: host-virus stand-off. Nat. Rev. Microbiol. 4:121&#x2013;132</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7096820</ArticleId><ArticleId IdType="pubmed">16415928</ArticleId></ArticleIdList></Reference><Reference><Citation>Muir P, Nicholson F, Sharief MK, Thompson EJ, Cairns NJ, Lantos P, Spencer GT, Kaminski HJ, Banatvala JE. 1995. Evidence for persistent enterovirus infection of the central nervous system in patients with previous paralytic poliomyelitis. Ann. N. Y. Acad. Sci. 753:219&#x2013;232</Citation><ArticleIdList><ArticleId IdType="pubmed">7611631</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger MM, Kopp N, Vital C, Redl B, Aymard M, Lina B. 2000. Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology 54:20&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pubmed">10636120</ArticleId></ArticleIdList></Reference><Reference><Citation>Stacey G, Viviani B. 2001. Cell culture models for neurotoxicology. Cell Biol. Toxicol. 17:319&#x2013;334</Citation><ArticleIdList><ArticleId IdType="pubmed">11768597</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein GH. 1979. T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. J. Cell. Physiol. 99:43&#x2013;54</Citation><ArticleIdList><ArticleId IdType="pubmed">222778</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Zhang X, Zhou G, Xiang X, Ji X, Zheng Z, He Z, Wang H. 2012. Simultaneous determination of human enterovirus 71 and coxsackievirus B3 by dual-color quantum dots and homogeneous immunoassay. Anal. Chem. 84:3200&#x2013;3207</Citation><ArticleIdList><ArticleId IdType="pubmed">22390751</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo MH, Hannemann H, Kulkarni AS, Schwartz PH, O'Dowd JM, Fortunato EA. 2010. Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells. J. Virol. 84:3528&#x2013;3541</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2838134</ArticleId><ArticleId IdType="pubmed">20071566</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo MH, Schwartz PH, Fortunato EA. 2008. Neonatal neural progenitor cells and their neuronal and glial cell derivatives are fully permissive for human cytomegalovirus infection. J. Virol. 82:9994&#x2013;10007</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2566273</ArticleId><ArticleId IdType="pubmed">18684829</ArticleId></ArticleIdList></Reference><Reference><Citation>Arndt U, Wennemuth G, Barth P, Nain M, Al-Abed Y, Meinhardt A, Gemsa D, Bacher M. 2002. Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J. Virol. 76:9298&#x2013;9306</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136427</ArticleId><ArticleId IdType="pubmed">12186913</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C-J, Lin H-R, Liao C-L, Lin Y-L. 2008. Cholesterol effectively blocks entry of flavivirus. J. Virol. 82:6470&#x2013;6480</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2447114</ArticleId><ArticleId IdType="pubmed">18448543</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S, Haisch C, Lodge P. 1990. Functional diversity in vascular endothelial cells: role in coxsackievirus tropism. J. Virol. 64:4516&#x2013;4522</Citation><ArticleIdList><ArticleId IdType="pmc">PMC247922</ArticleId><ArticleId IdType="pubmed">2166828</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessaud M, Autret A, Jegouic S, Balanant J, Joffret ML, Delpeyroux F. 2008. Development of a TaqMan RT-PCR assay for the detection and quantification of negatively stranded RNA of human enteroviruses: evidence for false-priming and improvement by tagged RT-PCR. J. Virol. Methods 153:182&#x2013;189</Citation><ArticleIdList><ArticleId IdType="pubmed">18706930</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafren DR, Williams DT, Barry RD. 1997. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. J. Virol. 71:9844&#x2013;9848</Citation><ArticleIdList><ArticleId IdType="pmc">PMC230302</ArticleId><ArticleId IdType="pubmed">9371658</ArticleId></ArticleIdList></Reference><Reference><Citation>Schowalter RM, Pastrana DV, Buck CB. 2011. Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog. 7:e1002161.10.1371/journal.ppat.1002161</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002161</ArticleId><ArticleId IdType="pmc">PMC3145800</ArticleId><ArticleId IdType="pubmed">21829355</ArticleId></ArticleIdList></Reference><Reference><Citation>Klump WM, Bergmann I, Muller BC, Ameis D, Kandolf R. 1990. Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5&#x2032; uridine residues are regained during plus-strand RNA synthesis. J. Virol. 64:1573&#x2013;1583</Citation><ArticleIdList><ArticleId IdType="pmc">PMC249292</ArticleId><ArticleId IdType="pubmed">2157045</ArticleId></ArticleIdList></Reference><Reference><Citation>Melchers WJ, Hoenderop JG, Bruins Slot HJ, Pleij CW, Pilipenko EV, Agol VI, Galama JM. 1997. Kissing of the two predominant hairpin loops in the coxsackie B virus 3&#x2032; untranslated region is the essential structural feature of the origin of replication required for negative-strand RNA synthesis. J. Virol. 71:686&#x2013;696</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191101</ArticleId><ArticleId IdType="pubmed">8985400</ArticleId></ArticleIdList></Reference><Reference><Citation>Harkins S, Cornell CT, Whitton JL. 2005. Analysis of translational initiation in coxsackievirus B3 suggests an alternative explanation for the high frequency of R+4 in the eukaryotic consensus motif. J. Virol. 79:987&#x2013;996</Citation><ArticleIdList><ArticleId IdType="pmc">PMC538586</ArticleId><ArticleId IdType="pubmed">15613327</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawicki SG, Lu JH, Holmes KV. 1995. Persistent infection of cultured cells with mouse hepatitis virus (MHV) results from the epigenetic expression of the MHV receptor. J. Virol. 69:5535&#x2013;5543</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189405</ArticleId><ArticleId IdType="pubmed">7636998</ArticleId></ArticleIdList></Reference><Reference><Citation>Chehadeh W, Kerr-Conte J, Pattou F, Alm G, Lefebvre J, Wattre P, Hober D. 2000. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J. Virol. 74:10153&#x2013;10164</Citation><ArticleIdList><ArticleId IdType="pmc">PMC102054</ArticleId><ArticleId IdType="pubmed">11024144</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferenczy MW, Johnson KR, Marshall LJ, Monaco MC, Major EO. 2013. Differentiation of human fetal multipotential neural progenitor cells to astrocytes reveals susceptibility factors for JC virus. J. Virol. 87:6221&#x2013;6231</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3648089</ArticleId><ArticleId IdType="pubmed">23536657</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA. 2006. Enterovirus surveillance&#x2014;United States, 1970-2005. MMWR Surveill Summ. 55(SS-08):1&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pubmed">16971890</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Z, Song Y, Li Y, Liu Y, Jiang P, Lin X, Liu G, Song L, Wang H, Xu A. 2012. Coxsackievirus B3, Shandong Province, China, 1990-2010. Emerg. Infect. Dis. 18:1865&#x2013;1867</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3559141</ArticleId><ArticleId IdType="pubmed">23092737</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. 2004. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J. Virol. 78:7916&#x2013;7924</Citation><ArticleIdList><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen YY, Chang TY, Chen ST, Li C, Liu HS. 2003. Comparative study of enterovirus 71 infection of human cell lines. J. Med. Virol. 70:109&#x2013;118</Citation><ArticleIdList><ArticleId IdType="pubmed">12629651</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard S, Couderc T, Destombes J, Thiesson D, Delpeyroux F, Blondel B. 1999. Poliovirus induces apoptosis in the mouse central nervous system. J. Virol. 73:6066&#x2013;6072</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112668</ArticleId><ArticleId IdType="pubmed">10364359</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabor-Godwin JM, Ruller CM, Bagalso N, An N, Pagarigan RR, Harkins S, Gilbert PE, Kiosses WB, Gude NA, Cornell CT, Doran KS, Sussman MA, Whitton JL, Feuer R. 2010. A novel population of myeloid cells responding to coxsackievirus infection assists in the dissemination of virus within the neonatal CNS. J. Neurosci. 30:8676&#x2013;8691</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2902258</ArticleId><ArticleId IdType="pubmed">20573913</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL. 2003. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am. J. Pathol. 163:1379&#x2013;1393</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868316</ArticleId><ArticleId IdType="pubmed">14507646</ArticleId></ArticleIdList></Reference><Reference><Citation>Conaldi PG, Serra C, Mossa A, Falcone V, Basolo F, Camussi G, Dolei A, Toniolo A. 1997. Persistent infection of human vascular endothelial cells by group B coxsackieviruses. J. Infect. Dis. 175:693&#x2013;696</Citation><ArticleIdList><ArticleId IdType="pubmed">9041346</ArticleId></ArticleIdList></Reference><Reference><Citation>Matteucci D, Paglianti M, Giangregorio AM, Capobianchi MR, Dianzani F, Bendinelli M. 1985. Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines. J. Virol. 56:651&#x2013;654</Citation><ArticleIdList><ArticleId IdType="pmc">PMC252628</ArticleId><ArticleId IdType="pubmed">2997486</ArticleId></ArticleIdList></Reference><Reference><Citation>Werk D, Schubert S, Lindig V, Grunert HP, Zeichhardt H, Erdmann VA, Kurreck J. 2005. Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of coxsackievirus B3 and its cognate coxsackievirus-adenovirus receptor. Biol. Chem. 386:857&#x2013;863</Citation><ArticleIdList><ArticleId IdType="pubmed">16164410</ArticleId></ArticleIdList></Reference><Reference><Citation>Fechner H, Pinkert S, Wang X, Sipo I, Suckau L, Kurreck J, Dorner A, Sollerbrant K, Zeichhardt H, Grunert HP, Vetter R, Schultheiss HP, Poller W. 2007. Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor. Gene Ther. 14:960&#x2013;971</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7091640</ArticleId><ArticleId IdType="pubmed">17377597</ArticleId></ArticleIdList></Reference><Reference><Citation>Zautner AE, Korner U, Henke A, Badorff C, Schmidtke M. 2003. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection. J. Virol. 77:10071&#x2013;10077</Citation><ArticleIdList><ArticleId IdType="pmc">PMC224569</ArticleId><ArticleId IdType="pubmed">12941917</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Poh CL, Sam IC, Chan YF. 2013. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J. Virol. 87:611&#x2013;620</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer SM, Kortekaas J, de Haan CA, Rottier PJ, Moormann RJ, Bosch BJ. 2012. Heparan sulfate facilitates Rift Valley fever virus entry into the cell. J. Virol. 86:13767&#x2013;13771</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3503077</ArticleId><ArticleId IdType="pubmed">23015725</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeish NJ, Williams CH, Kaloudas D, Roivainen MM, Stanway G. 2012. Symmetry-related clustering of positive charges is a common mechanism for heparan sulfate binding in enteroviruses. J. Virol. 86:11163&#x2013;11170</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3457184</ArticleId><ArticleId IdType="pubmed">22855495</ArticleId></ArticleIdList></Reference><Reference><Citation>Zautner AE, Jahn B, Hammerschmidt E, Wutzler P, Schmidtke M. 2006. N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells. J. Virol. 80:6629&#x2013;6636</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1488958</ArticleId><ArticleId IdType="pubmed">16775350</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodfellow IG, Sioofy AB, Powell RM, Evans DJ. 2001. Echoviruses bind heparan sulfate at the cell surface. J. Virol. 75:4918&#x2013;4921</Citation><ArticleIdList><ArticleId IdType="pmc">PMC114248</ArticleId><ArticleId IdType="pubmed">11312365</ArticleId></ArticleIdList></Reference><Reference><Citation>Misinzo G, Delputte PL, Meerts P, Lefebvre DJ, Nauwynck HJ. 2006. Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells. J. Virol. 80:3487&#x2013;3494</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1440380</ArticleId><ArticleId IdType="pubmed">16537616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E, Okumura M, Sawa H, Miyazaki T, Fujikura D, Yamada S, Sugahara K, Sasaki M, Kimura T. 2011. Paradoxical effects of chondroitin sulfate-E on Japanese encephalitis viral infection. Biochem. Biophys. Res. Commun. 409:717&#x2013;722</Citation><ArticleIdList><ArticleId IdType="pubmed">21621516</ArticleId></ArticleIdList></Reference><Reference><Citation>Dow KE, Wang W. 1998. Cell biology of astrocyte proteoglycans. Cell. Mol. Life Sci. 54:567&#x2013;581</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11147398</ArticleId><ArticleId IdType="pubmed">9676576</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka N, Sato M, Lamphier MS, Nozawa H, Oda E, Noguchi S, Schreiber RD, Tsujimoto Y, Taniguchi T. 1998. Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 3:29&#x2013;37</Citation><ArticleIdList><ArticleId IdType="pubmed">9581980</ArticleId></ArticleIdList></Reference><Reference><Citation>Balachandran S, Roberts PC, Kipperman T, Bhalla KN, Compans RW, Archer DR, Barber GN. 2000. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. J. Virol. 74:1513&#x2013;1523</Citation><ArticleIdList><ArticleId IdType="pmc">PMC111487</ArticleId><ArticleId IdType="pubmed">10627563</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair A, Frederick TJ, Miller SD. 2008. Astrocytes in multiple sclerosis: a product of their environment. Cell. Mol. Life Sci. 65:2702&#x2013;2720</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2858316</ArticleId><ArticleId IdType="pubmed">18516496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosking MP, Lane TE. 2010. The role of chemokines during viral infection of the CNS. PLoS Pathog. 6:e1000937.10.1371/journal.ppat.1000937</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000937</ArticleId><ArticleId IdType="pmc">PMC2912390</ArticleId><ArticleId IdType="pubmed">20686655</ArticleId></ArticleIdList></Reference><Reference><Citation>Narasipura SD, Henderson LJ, Fu SW, Chen L, Kashanchi F, Al-Harthi L. 2012. Role of beta-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes. J. Virol. 86:1911&#x2013;1921</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302377</ArticleId><ArticleId IdType="pubmed">22156527</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>